News for hackers. Stuff that matters.
Re:Big Pharma spends billions more on executives and stockho... by tfourb on Saturday February 17, 2024 @11:40AM (#39411022)
that's not really a contradiction to what I wrote above. The point of having one central negotiator is that this negotiator has a lot more leverage, because they control the demand of an entire market. If I tell a drug company, that they can sell me drug A for $X per dose or not sell any of drug A at all, you can except a lot more pressure on prices compared to negotiating only for one insurance plan among dozens.

There are no comments on this comment yet.